Wednesday February 24, 2021
  • |Subscribe
  • |Contribute
  • |About
  • |Access Your Account
  • |Register
  • |Login
  • |Home
  • |Current Issue
  • |Issue Archive
    • |Featured Reports
    • |eBooks
  • |BioProcess Insider
  • |Multimedia
    • |BPI White Papers
    • |Webinars
    • |Posters
  • |BioProcess International Events
    • |BioProcess International West
    • |COVID-19 Therapeutic Development & Production
  • |BioProcess International Academy
  • |Events

BioProcess International

Covering the whole development process for the global biotechnology industry

  • Upstream
    Processing
    Bioprocessing begins upstream, most often with culturing of animal or microbial cells in a range of vessel types (such as bags or stirred tanks) using different controlled feeding, aerating, and process strategies.
    • Assays
    • Biochemicals/Raw Materials
    • Bioreactors
    • Cell Culture Media
    • Expression Platforms
    • Fermentation
    • Perfusion Cell Culture
    • Upstream Contract Services
    • Upstream Single-Use Technologies
  • Downstream
    Processing
    Beginning with harvest of material from a bioreactor, downstream processing removes or reduces contaminants to acceptable levels through several steps that typically include centrifugation, filtration, and/or chromatographic technologies.
    • Filtration
    • Separation/Purification
    • Viral Clearance
    • Chromatography
    • Downstream Contract Services
    • Downstream Single-Use Technologies
  • Manufacturing
    Drug products combine active pharmaceutical ingredients with excipients in a final formulation for delivery to patients in liquid or lyophilized (freeze-dried) packaged forms — with the latter requiring reconstitution in the clinical setting.
    • Personalized Medicine
    • Single Use
    • Supply Chain
    • Vaccines
    • MAb
    • Biosimilars
    • Cell/Gene Therapies
    • Emerging Therapeutics
    • Facility Design/Engineering
    • Continuous Bioprocessing
    • Fill/Finish
    • Formulation
    • Information Technology
    • Manufacturing Contract Services
    • Process Monitoring and Controls
  • Analytical
    Many technologies are used to characterize biological products, manufacturing processes, and raw materials. The number of options and applications is growing every day — with quality by design (QbD) giving impetus to this expansion.
    • Culture Development
    • Cell Line Development
    • Downstream Development
    • Downstream Validation
    • Laboratory Equipment
    • PAT
    • Pre-Formulation
    • Product Characterization
    • QA/QC
    • Upstream Development
    • Upstream Validation
    • Leachables/Extractables/Particulates
  • Business
    Even as it matures, the biopharmaceutical industry is still a highly entrepreneurial one. Partnerships of many kinds — from outsourcing to licensing agreements to consultancies — help companies navigate this increasingly global business environment.
    • Careers
    • CMC Forums
    • Economics
    • Intellectual Property
    • Pre-Clinical and Clinical Trials
    • Regulatory Affairs
    • Risk Management
    • BioRegions

June 2003

The Real Biomanufacturing Capacity Crisis

by BPI Contributor
Add Comment
June 1, 2003

Our Readers Respond

by BPI Contributor
Add Comment
June 1, 2003

Products, Services, and Literature

by BPI Contributor
Add Comment
June 1, 2003

Scaling-Up from Bench to Clinic and Beyond

by BPI Contributor
Add Comment
June 1, 2003

GMP Compliance and Pilot Plant Manufacture

by BPI Contributor
Add Comment
June 1, 2003

Rising to the Challenge

by BPI Contributor
Add Comment
June 1, 2003

Planning Pharmaceutical Manufacturing Strategies in an Uncertain World

by BPI Contributor
Add Comment
June 1, 2003

Building a GMP Bacterial and Fungal Fermentation Facility

by BPI Contributor
Add Comment
June 1, 2003

A Modular Approach to Building Biotech Facilities

by BPI Contributor
Add Comment
June 1, 2003

Editor’s Choice

  • BioProcess Insider

    Bluebird Bio investigating potential vector role in AML and MDS cases

  • BioProcess Insider

    Resilience bags Sanofi-Genzyme plant in Boston

  • Sponsored Content

    Transfection Reagents for Cell and Gene Therapy

  • BioProcess Insider

    Workforce, tax incentives and US access attract more biotechs to Puerto Rico

  • BioProcess Insider

    Pfizer cites ‘simplicity’ of mRNA production to overcome COVID-19 variants

  • Sponsored Content

    Integrated mRNA Production Process from E. coli to Highly Purified mRNA

BioProcess Insider News and Analysis

Recent Tweets

  • Tweet Avatar RT @Dan5tanton: $CRL Charles River to reenter #CDMO space in $875m Cognate buy - Deal adds autologous and allogeneic #celltherapy,… https://t.co/h0diaBSQgw 6 days ago
  • Tweet Avatar RT @Dan5tanton: Pfizer expects to cut COVID-19 vaccine production time by close to 50% as production ramps up, efficiencies increas… https://t.co/yGbnpWCK0J 2 weeks ago
  • Tweet Avatar Pfizer says it is relatively simple to rejig the formulation and manufacturing infrastructure for its approved mRNA… https://t.co/abKZM3VsSS 3 weeks ago
  • Tweet Avatar RT @PharmSource: .@FionaReporter @Pharma_GD says “We are seeing strong investment by the largest #CDMO s in acquiring… https://t.co/OVsSUY0gJA 3 weeks ago
Follow @bioproinsider

Trending

  • BioProcess Insider

    Gilead Sciences partner with Gritstone for potential HIV cure

  • BioProcess Insider

    Resilience bags Sanofi-Genzyme plant in Boston

  • BioProcess Insider

    Pfizer cites ‘simplicity’ of mRNA production to overcome COVID-19 variants

  • BioProcess Insider

    Workforce, tax incentives and US access attract more biotechs to Puerto Rico

Explore Topics

  • Upstream Processing
  • Downstream Processing
  • Manufacturing
  • Analytical
  • Business

Publication

  • Issue Archive
  • Featured Reports
  • eBooks
  • Subscribe
Connect
Privacy policy

BioProcessIntl.com

  • White Papers
  • Posters
  • Webinars
  • BPI Theater
  • Awards
  • Register
  • Login
  • Access Your Account

Keep up with BPI

  • Email Newsletters
  • Events
  • BioProcess Insider
  • Twitter
  • LinkedIn

About BPI

  • Who We Are
  • Editorial Advisors
  • Author Guidelines
  • Advertising/Media Kit
  • List Rental/Reprints
  • Contact Us
  • Careers
BPI
twitter linkedin
Site Map|Contact
©2021 BioProcess International All Rights reserved
  • Home
  • Current Issue
  • Issue Archive
    â–¼
    • Featured Reports
    • eBooks
  • BioProcess Insider
  • Multimedia
    â–¼
    • BPI White Papers
    • Webinars
    • Posters
  • BioProcess International Events
    â–¼
    • BioProcess International West
    • COVID-19 Therapeutic Development & Production
  • BioProcess International Academy
  • Events